Cardinal Glennon Children's Hospital
1465 South Grand Boulevard
St. Louis, MO 63104-1095
Direct phone: (314) 577-5638
Total transplants by cell source
- Marrow: 1
- PBSC: 2
- Cord Blood: 8
- Autologous (PBSC or Marrow): 6
About the center
The Cardinal Glennon transplant team works closely with Be the Match to ensure the best possible donor choice (related/unrelated/umbilical cord blood) to treat a variety of malignant and non-malignant diseases. Our multidisciplinary team works tirelessly to ensure that the transplant process is as successful and smooth as possible. We are members of all cooperative groups doing research on transplants in order to be able to offer the latest transplant technology.
This center has been performing allogeneic transplants since 1994 and has been an NMDP/Be The Match transplant center since July 1998.
Pediatric - Aleksandar Babic, Deepika Bhatla, William Ferguson, Christopher Hugge, Shermini Saini
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Each year, approximately 70 children in the St. Louis area are diagnosed with cancer and seek treatment at SSM Health Cardinal Glennon. The Costas Center enables a comprehensive, multi-disciplinary approach to diagnose and treat children with cancer and blood disorders. Our world-class expertise in pediatric surgery, neurosurgery, tumor orthopedic surgery, radiology, radiation oncology and clinical pathology are all necessary components for the successful treatment of pediatric cancer. The Costas Center provides a comfortable setting for children to receive prolonged treatments, such as chemotherapy, transfusions or other drug treatments, without having to be admitted to the hospital. The center includes a 16-bed inpatient unit, day hospital and stem cell transplant unit.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 15 patients.
The actual 1-year survival of these patients is 86.7%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 57.6% and 97.3%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
(314) 268-2700 (ext 6315)
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)